Jyoti D Patel

The best cancer care starts with the best cancer information. https://t.co/XiNiOzyKA1 brings the expertise and resources of #ASCO to people living with cancer. The https://t.co/XiNiOzyKA1 mobile app helps manage care, get updates, and stay informed. https://t.co/mp1YveHd0y

CancerDotNet @CancerDotNet

Are you or a loved one making decisions about #CancerTreatment? https://t.co/z7njHqlfPw has expert information and resources to help understand a diagnosis, navigate care, and make informed decisions. https://t.co/WjW7AvYtBV #Chemotherapy #Immunotherapy #RadiationTherapy

RT @CharuAggarwalMD: #ASCO23 @ASCO Presenting on real world outcomes of 1L ICI in KRASG12C MT #NSCLC ➡️ Pts with KRASMT TPS<1 have worse O…

#ASCO23 Partnering with Patients and bringing impactful advances to the bedside. #CancerDotNet is a powerful resource for people with cancer, people who know someone with cancer, and all of us who want to decrease the burden of this disease.

CancerDotNet @CancerDotNet

❗New❗#ASCO23 study summary for patients: Adding nivolumab to #Chemotherapy reduces risk of cancer-related death in people with newly diagnosed, advanced #HodgkinLymphoma https://t.co/CaNk4z0w7b #LYMSM #SWOGS1826

Clinical trials remain vitally important in improving cancer outcomes. In fact, all of our best therapies were once studied in a clinical trials. Participants in a trial have potential access to tomorrow’s treatments, more options, and extra oversight. #Lurie #lcsm

CancerDotNet @CancerDotNet

Talking with your #Oncologist is the first step in finding a #ClinicalTrial for #CancerTreatment. @UCSDHealth's Dr. Ezra Cohen shares 4 steps for patients when considering #ClinicalTrials and resources for beginning the search https://t.co/JQyod8xLTP

Today, on #WorldCancerDay, February 4, let’s come together in our commitment to end cancer. Think about how what you can do to #CloseTheCareGap https://t.co/VSEupPfKjS

CancerDotNet @CancerDotNet

Tomorrow, we celebrate #WorldCancerDay and will reimagine a world where millions of #Cancer deaths are prevented & #CancerCare is equitable for all. In this post @JPatelMD shares ways we can all help #CloseTheCareGap https://t.co/9zHhodvdvB #HealthEquity #GlobalCancer @uicc

Excellent and important work. Understanding SCLC’s state diversity, likely a major feature of its clinical versatility and lethality, will help us improve outcomes🙌Congratulations @theabzlab !!

Mohamed Abazeed, MD, PhD @theabzlab

It's out! A mammoth resource and analytical effort that reveals how single-cell transition behaviors promote cell state equilibrium in small cell lung cancer. https://t.co/Y4Ct5USBJ3. Tweetorial to follow. https://t.co/MjyuVIofS3

Excited to share #RWD to examine outcomes to ICI vs ICI+CTx in NSCLC with KRAS, STK11, KEAP1 mutations #SITC2022. This is a heterogenous group & requires a tailored approach. This data has implications not only for treatment selection but also for trial design #LCSM https://t.co/E5HX1MZsBe

RT @TarnekaManning: We’re recognizing and celebrating our Lung Cancer patients @LurieCancer this November. #LungCancerAwarenessMonth #shine…

So great to walk in solidarity to improve lung cancer outcomes. Thank you to the patients, families, caregivers, healthcare providers and researchers who come together to affirm our commitment @LurieCancer @NorthwesternMed #lcsm https://t.co/Ad5zbNoNxC

Lung Cancer Research Foundation @lcrf_org

Chicago is showing up for #lungcancer research! #freetobreathe #freetobreathewalk https://t.co/2tkpNwcIhl

SCLC updates at #NACLC22. Dr Saiama Waqar reviews second line strategies. @ajuloorimd discusses implications of radiation in improving outcomes-survival and the quality of that survival. Fantastic panel @gdurm @jillfeldman4 Dr. Siddharth’s Devarakonda @ShrutiPatelMD @IASLC https://t.co/9GEN4gGI7Y

Reducing systemic barriers is essential to improve healthcare for all. We can do this. @d_dressler92 @joerfuchs @c_vakka @NU_IntMed @LurieCancer

Drew Moghanaki @DrewMoghanaki

Is Racial Inequity getting you down? Then, you might want to read this. @JPatelMD #NACLC22 #lcsm https://t.co/eUNDTLbjT2

Dr. Marianne Davies @YaleCancer presenting on survivorship issues in post ICI curative setting. We have much to learn and there is room for improvement as we increase the number of lung cancer survivors! @IASLC #NACLC22 https://t.co/AofM7OpHbJ

And we’re off! Morning session chaired by @jdoningtonmd and Nisha Mohindra @LurieCancer Impact of ICIs in NSCLC-Implications of Cure.#NACLC @IASLC https://t.co/3iJPrSU7xi

Wonderful team effort!

Stephen V Liu, MD @StephenVLiu

Excited for #NACLC22 with a thoracic oncology powerhouse trio of chairs: Drs. @JPatelMD @jdoningtonmd @marinagarassino #LCSM https://t.co/3v74g1cr1t

Many opportunities for collaboration and learning from each other! #NACLC22 starting soon-stellar educational and scientific content! @IASLC

Stephen V Liu, MD @StephenVLiu

Multi-disciplinary friends ready for the @IASLC #NACLC22 meeting! https://t.co/1qNHLlfqx7

Multi-Cancer Early Detection tests are promising-a new era in cancer care!

Multicancer Early Detection (MCED) Consortium @MCED_Consortium

Just released! A new article featuring, the #MCED Consortium and Dr. @JyotiPatel, our US Deputy Chair for the Communication Workgroup. Please read and share! https://t.co/9bgsTq2Nc1

Join us as we learn from each other, see old friends, and forge new collaborations while celebrating Dr. Landsberg’s legacy. @NU_IntMed @Anand_88_Patel @NorthwesternMed

Landsberg Society @Landsberg_Soc

We are ONE MONTH away from Weekend Update! We have an incredible lineup and are looking forward to having you all join us! Register Here: https://t.co/MQh4j5f0aH Check out our brochure: https://t.co/GoSZiwVnLa https://t.co/spQel2NJVD